Ventas, Inc. (VTR)

$63.55

-0.75

(-1.17%)▲

Market is closed - opens 8 PM, 25 Nov 2024

Performance

  • $63.43
    $64.68
    $63.55
    downward going graph

    0.19%

    Downside

    Day's Volatility :1.93%

    Upside

    1.74%

    downward going graph
  • $41.45
    $67.61
    $63.55
    downward going graph

    34.78%

    Downside

    52 Weeks Volatility :38.69%

    Upside

    6.01%

    downward going graph

Returns

PeriodVentas, Inc.Sector (Real Estate)S&P500
3 Months
6.16%
1.7%
5.9%
6 Months
33.79%
18.0%
12.5%
1 Year
40.88%
21.4%
30.9%
3 Years
23.81%
-10.3%
27.0%

Highlights

Market Capitalization
27.0B
Book Value
$23.28
Dividend Share
1.8
Dividend Yield
2.81%
Earnings Per Share (EPS)
-0.14
PEG Ratio
2.28
Wall Street Target Price
70.211
Profit Margin
-1.39%
Operating Margin TTM
15.88%
Return On Assets TTM
1.75%
Return On Equity TTM
-0.54%
Revenue TTM
4.8B
Revenue Per Share TTM
11.78
Quarterly Revenue Growth YOY
8.0%
Gross Profit TTM
1.8B
EBITDA
1.9B
Diluted Eps TTM
-0.14
Quarterly Earnings Growth YOY
-0.82
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.38
EPS Estimate Current Quarter
-0.03
EPS Estimate Next Quarter
-0.05

Analyst Recommendation

Buy
    70%Buy
    29%Hold
    0
    0%Sell
Based on 24 Wall street analysts offering stock ratings for Ventas, Inc.(by analysts ranked 0 to 5 stars)
Based on 24 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
17
16
17
Hold
7
8
8
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 10.48%

Current $63.55
Target $70.21

Company Financials

FY18Y/Y Change
Revenue
3.7B
↑ 4.8%
Net Income
409.5M
↓ 69.81%
Net Profit Margin
10.93%
↓ 27.02%
FY19Y/Y Change
Revenue
3.9B
↑ 3.39%
Net Income
433.0M
↑ 5.75%
Net Profit Margin
11.18%
↑ 0.25%
FY20Y/Y Change
Revenue
3.8B
↓ 2.0%
Net Income
439.1M
↑ 1.42%
Net Profit Margin
11.57%
↑ 0.39%
FY21Y/Y Change
Revenue
3.8B
↑ 0.86%
Net Income
49.0M
↓ 88.84%
Net Profit Margin
1.28%
↓ 10.29%
FY22Y/Y Change
Revenue
4.1B
↑ 7.87%
Net Income
-40.9M
↓ 183.52%
Net Profit Margin
-0.99%
↓ 2.27%
FY23Y/Y Change
Revenue
4.5B
↑ 8.93%
Net Income
-41.0M
↑ 0.1%
Net Profit Margin
-0.91%
↑ 0.08%
Q2 FY23Q/Q Change
Revenue
1.1B
↑ 2.7%
Net Income
103.5M
↑ 490.59%
Net Profit Margin
9.35%
↑ 7.72%
Q3 FY23Q/Q Change
Revenue
1.1B
↑ 3.93%
Net Income
-71.1M
↓ 168.75%
Net Profit Margin
-6.19%
↓ 15.54%
Q4 FY23Q/Q Change
Revenue
1.2B
↑ 1.27%
Net Income
-90.8M
↑ 27.69%
Net Profit Margin
-7.8%
↓ 1.61%
Q1 FY24Q/Q Change
Revenue
1.2B
↑ 3.05%
Net Income
-14.3M
↓ 84.24%
Net Profit Margin
-1.19%
↑ 6.61%
Q2 FY24Q/Q Change
Revenue
1.2B
↑ 0.09%
Net Income
19.4M
↓ 235.46%
Net Profit Margin
1.61%
↑ 2.8%
Q3 FY24Q/Q Change
Revenue
1.2B
↑ 2.94%
Net Income
50.0
↓ 100.0%
Net Profit Margin
0.0%
↓ 1.61%
FY18Y/Y Change
Total Assets
22.6B
↓ 5.72%
Total Liabilities
12.3B
↓ 5.45%
FY19Y/Y Change
Total Assets
24.7B
↑ 9.33%
Total Liabilities
14.1B
↑ 14.89%
FY20Y/Y Change
Total Assets
23.9B
↓ 3.09%
Total Liabilities
13.7B
↓ 3.5%
FY21Y/Y Change
Total Assets
24.7B
↑ 3.29%
Total Liabilities
13.8B
↑ 0.88%
FY22Y/Y Change
Total Assets
24.2B
↓ 2.27%
Total Liabilities
13.9B
↑ 1.19%
FY23Y/Y Change
Total Assets
24.7B
↑ 2.35%
Total Liabilities
14.9B
↑ 6.76%
Q2 FY23Q/Q Change
Total Assets
25.1B
↑ 4.49%
Total Liabilities
14.8B
↑ 8.05%
Q3 FY23Q/Q Change
Total Assets
25.0B
↓ 0.42%
Total Liabilities
14.8B
↑ 0.38%
Q4 FY23Q/Q Change
Total Assets
24.7B
↓ 0.97%
Total Liabilities
14.9B
↑ 0.35%
Q1 FY24Q/Q Change
Total Assets
24.7B
↓ 0.21%
Total Liabilities
14.9B
↑ 0.34%
Q2 FY24Q/Q Change
Total Assets
24.5B
↓ 0.58%
Total Liabilities
14.6B
↓ 2.53%
Q3 FY24Q/Q Change
Total Assets
25.3B
↑ 3.33%
Total Liabilities
15.2B
↑ 4.38%
FY18Y/Y Change
Operating Cash Flow
1.4B
↓ 4.21%
Investing Cash Flow
324.5M
↓ 133.23%
Financing Cash Flow
-1.8B
↑ 162.46%
FY19Y/Y Change
Operating Cash Flow
1.4B
↑ 4.08%
Investing Cash Flow
-1.6B
↓ 588.54%
Financing Cash Flow
160.7M
↓ 109.12%
FY20Y/Y Change
Operating Cash Flow
1.5B
↑ 0.86%
Investing Cash Flow
154.3M
↓ 109.73%
Financing Cash Flow
-1.3B
↓ 909.1%
FY21Y/Y Change
Operating Cash Flow
1.0B
↓ 29.24%
Investing Cash Flow
-724.1M
↓ 569.32%
Financing Cash Flow
-558.5M
↓ 57.04%
FY22Y/Y Change
Operating Cash Flow
1.1B
↑ 9.17%
Investing Cash Flow
-859.2M
↑ 18.65%
Financing Cash Flow
-283.9M
↓ 49.16%
Q2 FY23Q/Q Change
Operating Cash Flow
311.8M
↑ 28.42%
Investing Cash Flow
-71.3M
↑ 26.74%
Financing Cash Flow
-226.0M
↑ 39.4%
Q3 FY23Q/Q Change
Operating Cash Flow
360.8M
↑ 15.71%
Investing Cash Flow
-141.4M
↑ 98.23%
Financing Cash Flow
9.8M
↓ 104.33%

Technicals Summary

Sell

Neutral

Buy

Ventas, Inc. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Ventas, Inc.
Ventas, Inc.
-3.65%
33.79%
40.88%
23.81%
10.25%
Healthpeak Properties, Inc.
Healthpeak Properties, Inc.
-6.0%
13.19%
92.35%
17.31%
17.44%
Welltower Inc.
Welltower Inc.
4.45%
36.72%
53.88%
58.39%
65.78%
Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc.
-3.86%
27.45%
25.23%
37.46%
-3.67%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Ventas, Inc.
Ventas, Inc.
2223.5
NA
2.28
0.0
-0.01
0.02
0.03
23.28
Healthpeak Properties, Inc.
Healthpeak Properties, Inc.
44.31
44.31
4.08
0.15
0.04
0.02
0.06
12.24
Welltower Inc.
Welltower Inc.
87.82
87.82
2.33
1.46
0.03
0.02
0.02
49.05
Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc.
29.51
29.51
1.13
1.51
0.09
0.04
0.07
15.69
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Ventas, Inc.
Ventas, Inc.
Buy
$27.0B
10.25%
2223.5
-1.39%
Healthpeak Properties, Inc.
Healthpeak Properties, Inc.
Buy
$15.2B
17.44%
44.31
12.11%
Welltower Inc.
Welltower Inc.
Buy
$85.9B
65.78%
87.82
12.12%
Omega Healthcare Investors Inc.
Omega Healthcare Investors Inc.
Hold
$11.1B
-3.67%
29.51
34.41%

Insights on Ventas, Inc.

  • Increasing Revenue

    Revenue is up for the last 11 quarters, 1.01B → 1.23B (in $), with an average increase of 1.9% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, 19.38M → 50.0 (in $), with an average decrease of 100.0% per quarter

  • Vs DOC

    In the last 1 year, Healthpeak Properties, Inc. has given 92.3% return, outperforming this stock by 51.4%

Institutional Holdings

  • Vanguard Group Inc

    15.64%

  • BlackRock Inc

    10.32%

  • JPMorgan Chase & Co

    6.43%

  • State Street Corp

    6.22%

  • FMR Inc

    5.57%

  • Principal Financial Group Inc

    4.50%

Corporate Announcements

  • Ventas, Inc. Dividends March,2024

    In the quarter ending March,2024. Ventas, Inc. has declared dividend of $0.45

    Read More

Company Information

celebrating our 20th anniversary in 2018, ventas is an s&p; 500 company and leading real estate investment trust (reit). as the leading capital provider for healthcare real estate with more than $40 billion of investments under our belt, we own communities where patients and their families receive health and healing; where world class researchers discover treatments for disease; and where seniors live with dignity. our diverse property portfolio combines seniors housing, life science research and innovation centers, medical office buildings, health system complexes, and post-acute care facilities. thanks to our financial strength and liquidity, our stock and robust dividend provides secure retirement savings and income to pensioners, firefighters, teachers and individuals around the world. ventas takes our esg (environment, social & governance) commitments seriously, emphasizing strong corporate governance; encouraging community engagement through social and financial support to the co

Organization
Ventas, Inc.
Employees
486
CEO
Ms. Debra A. Cafaro
Industry
Finance

FAQs